Skip to main content
Clinical Trials/EUCTR2011-004567-80-AT
EUCTR2011-004567-80-AT
Active, Not Recruiting
N/A

The intraoperative arterial measurement of the blood flow after Iloproststimulation in diabetics and non-diabetics: Implication for Outcome - prediction and perioperative therapy. - ILOFLOW1.0

Georg Hagmüller Institute for Vascular Research0 sitesApril 18, 2012

Overview

Phase
N/A
Intervention
Not specified
Conditions
We think that the blood flow increases during intraarterial injection of iloprost during surgical treatment in distal vessels in patients with arteriosclerosis and diabetes and non diabetes in the same way because of vasodilatation. So we investigate people with arteriosclerosis and diabetes and non diabetes which undergo surgical treatment.
Sponsor
Georg Hagmüller Institute for Vascular Research
Status
Active, Not Recruiting
Last Updated
13 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 18, 2012
End Date
TBD
Last Updated
13 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Georg Hagmüller Institute for Vascular Research

Eligibility Criteria

Inclusion Criteria

  • patients between 18\-99 years, women, men, patients with diabetes and non\-diabetes, patients with arteriosclerosis and who undergo surgical treatment in distal vessels
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 30
  • F.1\.3 Elderly (\>\=65 years) yes
  • F.1\.3\.1 Number of subjects for this age range 30

Exclusion Criteria

  • pregnancy, heart attack, stroke in the last 6 months, hypotension, edema of the lungs, heart failure, heart diseases, COPD, ulcus ventriculi, renal diseases, coronary diseases, immaturity

Outcomes

Primary Outcomes

Not specified

Similar Trials